ASBMB announces 2024 class of fellows
2024-01-10
(Press-News.org) The American Society for Biochemistry and Molecular Biology today announced its 2024 class of fellows. The honorific program recognizes scientists who have made outstanding contributions to the field through their research, teaching, mentoring or other forms of service.
Edward Eisenstein, an associate professor of bioengineering at the University of Maryland and ASBMB Membership Committee chair, and Judith Bond, an adjunct professor of biochemistry and biophysics at the University of North Carolina at Chapel Hill and chair of the ASBMB Fellows Program Subcommittee, wrote in a joint statement: “The 17 ASBMB fellows in the 2024 class have shown immense commitment to ASBMB and represent an outstanding group of scientists ... It is an honor to have these individuals represent ASBMB, and we look forward to their continued contributions as role models and mentors to current and future members of the biochemistry and molecular biology community.”
The society will recognize the 17 new fellows at its annual meeting, Discover BMB, in March in San Antonio. The presentation will be part of the society's presidential address on Saturday, March 23.
The fellows are:
Toni M. Antalis, University of Maryland School of Medicine
David A. Bernlohr, University of Minnesota
Joan W. Conaway, University of Texas Southwestern Medical Center
Kathleen Cornely, Providence College
Martha S. Cyert, Stanford University
Nicholas O. Davidson, Washington University School of Medicine in St. Louis
Matthew S. Gentry, University of Florida College of Medicine
Marina K. Holz, New York Medical College
Mary O. Huff, Bellarmine University
Peter J. Kennelly, Virginia Polytechnic Institute and State University
Bettie Sue Masters, Duke University Medical Center
Richard C. Page, Miami University
Jennifer Roecklein–Canfield, Simmons University
Christopher E. Rohlman, Albion College
Walter A. Shaw, Avanti Polar Lipids Inc.
John T. Tansey, Otterbein University
Brian W. Wattenberg, Virginia Commonwealth University
About the American Society for Biochemistry and Molecular Biology (ASBMB)
The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Founded in 1906 to advance the science of biochemistry and molecular biology, the society publishes three peer-reviewed journals, advocates for funding of basic research and education, supports science education at all levels, and promotes the diversity of individuals entering the scientific workforce. www.asbmb.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-01-10
In nature, organic molecules are either left- or right-handed, but synthesizing molecules with a specific “handedness” in a lab is hard to do. Make a drug or enzyme with the wrong “handedness,” and it just won’t work. Now chemists at the University of California, Davis, are getting closer to mimicking nature’s chemical efficiency through computational modeling and physical experimentation.
In a study appearing Jan. 10 in Nature, Professor Dean Tantillo, graduate students William DeSnoo and Croix Laconsay, and colleagues at the Max Planck ...
2024-01-10
Overdose deaths in North America have skyrocketed, primarily because of the spread of illegally manufactured fentanyl. In a new study, researchers analyzed an early and prominent fentanyl-selling operation on the dark web. The organization sustained a significant growth rate, which allowed it to offer consumers steep discounts. In light of these findings, the authors conclude that it might be challenging to constrain supply by shuttering individual organizations since remaining organizations could grow rapidly to fill unmet demand.
The study was conducted by researchers at Carnegie ...
2024-01-10
Waltham — January 10, 2024 — Bottled water marketed as "alkaline water" is unlikely to be an effective alternative for prevention of recurrent urinary stones, reports a study in the January issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
"While alkaline water products have a higher pH than regular water, they have a negligible alkali content – ...
2024-01-10
WACO, Texas (Jan. 10, 2024) – A first-of-its-kind tactile learning device developed by Baylor University chemistry professors to make science accessible to students with blindness or low vision (BLV) has opened the possibility of the transfer of any scientific data or images for sighted students into functional, thorough formats for students with blindness. The study was published today in the journal Science Advances.
The latest research from Bryan F. Shaw, Ph.D., professor of chemistry and biochemistry at Baylor, focused on the development of a codex using lithophane – an ancient art form – to convert images from scientific textbooks into tactile ...
2024-01-10
Photonics offers various advantages, including enablement of high-speed and low-loss communication by leveraging light properties in optical data communication, biomedical applications, automotive technology, and artificial intelligence domains. These advantages are realized through complex photonic circuits, comprising diverse photonic elements that are integrated on a photonic chip. Electronic chips are then added to supplement the photonic chips for certain functions, such as light source operation, modulation, and amplification. The close integration of electronic and photonic chips on a substrate is a critical aspect of photonic packaging.
Photonic packaging plays a vital role in ...
2024-01-10
PITTSBURGH, Jan. 10, 2024 – University of Pittsburgh Schools of Medicine researchers uncovered a fundamental mechanism that controls the body’s response to limited oxygen and regulates blood vessel disease of the lung.
By combing through genomes of more than 20,000 individuals in the U.S., France, England and Japan and combining the results with molecular studies in the lab, the team discovered a shared genetic trait that could predict a higher risk of small lung vessel disease called pulmonary hypertension and its more severe ...
2024-01-10
By exploiting the technology used in Covid-19 vaccines, a team led by UCL, King’s College London and Moderna scientists has created an effective therapy for a rare disease, in a study in mice, demonstrating the technology’s potential therapeutic use in people.
The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.
Argininosuccinic aciduria is an inherited metabolic disorder that affects how the body ...
2024-01-10
Increases in symptoms of depression are associated with a subsequent increase in bodyweight when measured one month later, new research from the University of Cambridge has found.
The study, published today in PLOS ONE, found that the increase was only seen among people with overweight or obesity, but found no link between generally having greater symptoms of depression and higher bodyweight.
Research has suggested a connection between weight and mental health – with each potentially influencing the other – but the relationship is complex and remains poorly understood, ...
2024-01-10
WHAT:
An atlas revealing the activity of individual placental cells during childbirth offers insight on what happens at the maternal-fetal interface during term labor, according to a study supported by the National Institutes of Health (NIH). The atlas provides a single-cell analysis of the human placenta and its surrounding membranes and is the first to use this method to understand the communication that occurs between maternal and fetal cells during the process of labor. Studying these processes aids understanding of typical labor and delivery at term, as well as preterm labor and delivery, which occurs before ...
2024-01-10
Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how these effects arise is unknown. New research led by the University of Bristol explored their neuropsychological effects and found that all three of these drugs can modulate affective biases associated with learning and memory.
The paper, published in Science Translational Medicine today [10 January] was carried out in collaboration with researchers at Compass Pathways, Boehringer Ingelheim, and the University of Cambridge.
Negative affective ...
LAST 30 PRESS RELEASES:
[Press-News.org] ASBMB announces 2024 class of fellows
